| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $2.2B | $2.0B | $1.9B | $2.2B | $1.8B | $0.4B | $0.3B | $1.4B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | $0.7B | $0.7B | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $0.4B | $0.5B | $0.2B | $0.4B | $0.3B | $0.0B | $0.1B | $-0.0B |
| Net Income | $0.2B | $0.3B | $0.1B | $0.2B | $0.2B | $0.0B | $0.0B | $-0.1B |
| EPS (Basic) | $1.49 | $2.67 | $1.02 | $1.97 | $2.28 | $0.11 | $0.40 | $-0.70 |
| EPS (Diluted) | $1.48 | $2.67 | $1.02 | $1.97 | $2.27 | $0.10 | $0.40 | $-0.69 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $12.1B | $11.2B | $10.3B | $9.3B | $8.7B | $7.9B | $7.3B | $6.9B |
| Current Assets | $0.6B | $0.5B | $0.5B | $0.4B | $0.3B | $0.4B | $0.3B | $0.3B |
| Cash & Equivalents | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| Total Liabilities | $8.6B | $8.6B | $7.8B | $7.0B | $6.4B | $5.8B | $5.5B | $5.1B |
| Current Liabilities | $1.0B | $1.8B | $1.2B | $0.9B | $0.7B | $1.0B | $1.0B | $0.5B |
| Stockholders' Equity | $3.4B | $2.5B | $2.3B | $2.2B | $2.2B | $2.0B | $1.7B | $1.7B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.6B | $0.5B | $0.6B | $0.6B | $0.5B | $0.5B | $0.5B | $0.4B |
| Investing Cash Flow | $-1.2B | $-1.2B | $-1.1B | $-1.0B | $-1.0B | $-0.7B | $-0.7B | $-0.5B |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $0.6B | $0.7B | $0.5B | $0.4B | $0.4B | $0.3B | $0.2B | $0.0B |